Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: A feasibility study

CardioVascular and Interventional Radiology

Volumn 22, Issue 3, 1999, Pages 196-200

  Shibuya, Keiko ^a   Nagata, Yasushi ^a   Itoh, Tuyoshi ^b   Okajima, Kaoru ^b   Murata, Rumi ^a   Takagi, Takehisa ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Advanced pancreatic cancer; Computed tomography Preoperative regional chemotherapy Quality of life; Transcatheter arterial infusion

Indexed keywords

CA 19-9 ANTIGEN; EPIRUBICIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CELL DESTRUCTION; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CATHETERIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; EPIRUBICIN; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MITOMYCIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032997425     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002709900365     Document Type: Article

References (22)

1. Gall FP, Kockerling F (1988) The problem of radical surgery in pancreatic cancer and ils implications for a combined-treatment approach. Recent Results Cancer Res 110:79-86
2. Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161:26-30
3. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RES, Evans RG (1990) Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66:56-61
4. Howard TJ (1996) Pancreatic adenocarcinoma. Curr Probl Cancer 20(5):281-328
5. Arbuck SG (1990) Chemotherapy for pancreatic cancer. Baillieres Clin Gastroenterol 4:953-968
6. Arbuck SG (1990) Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 7:209-222
7. Matsuno S, Hisano H, Kobari M, Akaishi S (1990) Growth inhibitory effects of combination chemotherapy for human pancreatic cancer cell lines. Cancer 66:2369-2374
8. Smith FP, Hoth DF, Levin B, Karlin DA, MacDonald JS, Woolley PV III, Philip PS (1980) 5-fluorouracil, adriamycin, and mitomycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 46:2014-2018
9. Bukowski RM, Schacter LP, Groppe CW, Hewlett JS, Weick JK, Livingston RB (1982) Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma. Cancer 50:197-200
10. Muchmore JH (1995) Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration. Semin Surg Oncol 11:154-167
11. Bitran JD, Desser RK, Kazloff MF, Billings AA, Shapiro CM (1979) Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). Cancer Treat Rep 63:2049-2051
12. Hochster H, Green MD, Speyer JL, Wernz JC, Blum RH, Muggia FM (1986) Cancer Treat Rep 70:299-300
13. Suzuki T, Manabe T, Naitoh A, Miyashita T, Tobe T, Takahashi M, Abe M (1985) Multidisciplinary treatment of cancer of the pancreas. Gan To Kagaku Ryoho 12(2):235-244
14. Okawa T, Kita M (1988) Clinical evaluation of implantable drug delivery system (Port-A-Cath) in cancer chemotherapy. Gan To Kagaku Ryoho 15:2659-2663
15. Maruyama T, Koura Y, Kurisu Y, Kuroi K, Kai Y (1989) Intra-arterial infusion chemotherapy in non-resectable pancreatic cancer using angiotensin-II and implantable drug delivery system. Gan To Kagaku Ryoho 16:2735-2739
16. Aigner KR, Muller H, Bessermann R (1990) Intra-arterial chemotherapy with MMC, CDDP and 5-FU for non-resectable pancreatic cancer: A phase II study. Reg Cancer Treat 3:1-6
17. Muchmore JH, Preslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78:664-673
18. Ohigashi H, Ishikawa O, Imaoka S, Sasaki Y, Kabuto T, Kameyama M, Furukawa H, Hiratuka M, Nakamori S, Nakano H, Yasuda T, Iwanaga T (1992) A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepatogastroenterology 43:338-345
19. Kakizaki K, Yamauchi H, Takahashi N, Kikuti H, Asamura M (1989) Long-term arterial infusion chemotherapy in unresectable pancreatic cancer. Gan To Kagaku Ryoho 16:2740-2742
20. Yasuda T, Ishikawa O, Ohigashi H, Shibata T, Sasaki Y, Hiratsuka M, Kabuto T, Furukawa H, Imaoka S, Iwanaga T (1989) Preventive effects of intra-arterial infusion chemotherapy of liver metastasis in non-resectable pancreatic cancer. Gan To Kagaku Ryoho 16:2863-2866
21. Courteny VD, Mills J, Steel GG (1982) The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts. Br J Cancer 46:436-439
22. Chang BK (1983) Differential sensitivity of pancreatic adenocarcinoma cell lines to chemotherapeutic agents in culture. Cancer Treat Rep 67:355-361